research LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
This study identified LY191704 as a specific noncompetitive inhibitor of human 5 alpha-reductase type 1, which may be useful in treating endocrine disorders related to DHT overproduction.



